Boutique of Excellence: Laval Production Plant

In 2021, when Kedrion completed the acquisition of Prometic, the production plant of Laval hub is became one of Kedrion’s center of excellence for innovation. This is where Prometic has developed a process for purifying plasma proteins that is still unique today.

Based in Québec, Canada, the Laval production site has developed the first-ever therapy for the treatment of an ultra-rare and debilitating condition, Congenital Plasminogen Deficiency.